Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Horwitz

Showing results (701-710 of 717) with videos related to

Pageof 72
Sort By:
The New England Journal of Medicine|June 30, 2020
Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsLeora R Feldstein, Erica B Rose, Steven M Horwitz, et al.
Blood Advances|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomasRahul S Bhansali, Fredrik Ellin, Thomas Relander, et al.
Blood|July 15, 2025
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk StratificationJulia J Scarisbrick, Pietro Quaglino, Sean J Whittaker, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 30, 2023
Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUsMelania M Bembea, Laura L Loftis, Ravi R Thiagarajan, et al.
Eclinicalmedicine|September 6, 2021
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescentsAlon Geva, Manish M Patel, Margaret M Newhams, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
European Urology|May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate CancerRebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
JAMA|February 24, 2021
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19Leora R Feldstein, Mark W Tenforde, Kevin G Friedman, et al.
JAMA Oncology|January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 CohortsAmar U Kishan, Alison Steigler, James W Denham, et al.
JAMA Network Open|July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic FeaturesAmar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
Pageof 72

Showing results (701-710 of 717) with videos related to

Sort By:
Pageof 72
The New England Journal of Medicine|June 30, 2020
Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsLeora R Feldstein, Erica B Rose, Steven M Horwitz, et al.
Blood Advances|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomasRahul S Bhansali, Fredrik Ellin, Thomas Relander, et al.
Blood|July 15, 2025
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk StratificationJulia J Scarisbrick, Pietro Quaglino, Sean J Whittaker, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 30, 2023
Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUsMelania M Bembea, Laura L Loftis, Ravi R Thiagarajan, et al.
Eclinicalmedicine|September 6, 2021
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescentsAlon Geva, Manish M Patel, Margaret M Newhams, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
European Urology|May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate CancerRebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
JAMA|February 24, 2021
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19Leora R Feldstein, Mark W Tenforde, Kevin G Friedman, et al.
JAMA Oncology|January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 CohortsAmar U Kishan, Alison Steigler, James W Denham, et al.
JAMA Network Open|July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic FeaturesAmar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
Pageof 72